What factors drive Asia’s cervical cancer screening market?

Portable devices and point-of-care tests benefit rural areas.

Technological advancements are driving Asia’s cervical cancer screening market, which is projected to reach $3.76b by 2032 at a compound annual growth rate of 4.23%, according to Research and Markets.

Primary screening is increasingly conducted using advanced cytopathological methods, such as liquid-based techniques, HPV DNA detection, and computer-aided screening. Meanwhile, portable devices and point-of-care tests benefit screening in rural areas.

In line with this, artificial intelligence and machine learning in diagnostic tools are improving the accuracy and efficiency of screening results.

Meanwhile, governments across the region are recognising the importance of cervical cancer prevention and are launching national screening programmes.

“Some of the interventions comprise mass awareness campaigns, low-cost or free cervical cancer checks, and cervical cancer screening as a part of a general package in primary care,” the report said.

Moreover, non-governmental organisations and international health institutions are collaborating with local authorities to ensure such services reach rural and underprivileged populations.